Hinge Health's AI Moat Might Be Its Patient Movement Data

The cost of healthcare in the United States is on the rise in a big way. In its 2026 healthcare outlook, the Big Four accounting firm PricewaterhouseCoopers (PwC) made strong statements confirming this reality.

MarketBeat • Feb 23, 2026

The High‑Growth Healthcare Stock Early Investors Will Brag About for the Next Decade

Hinge Health is using artificial intelligence to keep physical therapy costs down for employers. The company improved revenue by 51% in 2025.

The Motley Fool • Feb 20, 2026

How Much Upside is Left in Hinge Health Inc. (HNGE)? Wall Street Analysts Think 38.96%

The average of price targets set by Wall Street analysts indicates a potential upside of 39% in Hinge Health Inc. (HNGE). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.

Zacks Investment Research • Feb 20, 2026

Hinge Health: More Immune To AI Than Most; A Fast-Growing, Highly Cash-Flowing Market Leader

Hinge Health combines robust 2025 growth (51% revenue, 31% FCF margin) with best-in-class digital MSK therapy, serving 24.6M covered lives. HNGE trades at 12–14x 2026 FCF, with management guiding 25% revenue growth but strong signals this is conservative. Defensibility against AI disruption is high due to healthcare barriers, proprietary data, hardware integration, and clinical outcomes, supporting a durable moat.

Seeking Alpha • Feb 18, 2026

Why Hinge Health Stock Popped on Wednesday

Hinge Health beat on top and bottom lines last night. Hinge is growing sales, earnings, and free cash flow rapidly, though growth could slow in 2026.

The Motley Fool • Feb 11, 2026

Why Is Hinge Health Stock Soaring Wednesday?

Hinge Health Inc. (NYSE: HNGE) stock rose Wednesday after the company reported better-than-expected fourth-quarter earnings.

Benzinga • Feb 11, 2026

Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript

Hinge Health, Inc. (HNGE) Q4 2025 Earnings Call Transcript

Seeking Alpha • Feb 11, 2026

Hinge Health reports fourth quarter and full year 2025 financial results

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health, Inc. (NYSE: HNGE) today announced record financial results for the quarter and year ended December 31, 2025. “We closed out the year with an exceptional quarter and a strong selling season, driving our highest win rates to date and greatest number of eligible lives added in any year,” said Daniel Perez, Co-Founder and CEO, Hinge Health. “Our commercial momentum, combined with expanding margins and strong cash generation, gives us confidence in our a.

Business Wire • Feb 10, 2026

Hinge Health's 2026 State of Musculoskeletal Care Report reveals stark gaps in traditional care

SAN FRANCISCO--(BUSINESS WIRE)--Today, Hinge Health (NYSE: HNGE) released its sixth annual State of Musculoskeletal (MSK) Care Report, revealing how today's fragmented healthcare system leaves many people unsure how to pursue treatment for MSK pain. Hinge Health surveyed 1,000 people living with MSK pain alongside 295 healthcare providers to understand the systemic challenges and opportunities for industry-wide improvements. The dual-perspective survey – along with real patient and provider sto.

Business Wire • Jan 15, 2026

Hinge Health to announce fourth quarter and full year 2025 financial results on February 10, 2026

SAN FRANCISCO--(BUSINESS WIRE)--Hinge Health Q4 2025 earnings date press release.

Business Wire • Jan 14, 2026